Fatty liver disease doubles risk of death from several diseases
Fatty liver disease, medically called metabolic dysfunction-associated steatotic liver disease (MASLD), affects millions globally. Around one in four adults worldwide...
Fatty liver disease, medically called metabolic dysfunction-associated steatotic liver disease (MASLD), affects millions globally. Around one in four adults worldwide...
Victoria's world-renowned Royal Children's Hospital (RCH) and Austin Health are celebrating the 250th paediatric liver transplant - a partnership that...
Beatrice Credi (Head of Office), European Liver Patients’ Association – ELPA International Women’s Day is a time to celebrate women’s...
LiveMultiScan from Perspectum A multinational study published in Nature Communications Medicine suggests that MR-based imaging is a cost-effective alternative to...
New research highlights the promise of artificial intelligence (AI) for opportunistic screening of chronic liver disease (CLD) through routine echocardiography. An...
DelveInsight’s, “Metastatic Liver Cancer Pipeline Insight” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Metastatic-Liver-Cancer pipeline...